Bone and Joint Infections

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2020-01-30
Clinical Trial Update: Oral Sodium Fusidate (CEM-102) for the Treatment of Staphylococcal Bone or Joint Infections [Phase 2, Phase 3]
Phase 2/3 trial update for oral sodium fusidate (CEM-102) in refractory bone or joint infections has completed, with results posted in 2020.